Augmedix, Inc. (AUGX) Tops Q4 EPS by 1c

Augmedix, Inc. (NASDAQ: AUGX) reported Q4 EPS of ($0.09), $0.01 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $12.68 million versus the consensus estimate of $12.47 million.

For earnings history and earnings-related data on Augmedix, Inc. (AUGX) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• SanDisk unveils long-term growth strategy at 2026 Investor Day; Shares surge 12%
• Live Ventures (LIVE) Reports Q3 Loss of $0.34